Risk Factors, Mechanisms and Treatments of Thromboangiitis Obliterans: An Overview of Recent Research.

Li, Meng-di; Wang, Yi-Fan; Yang, Mei-Wen; Hong, Fen-Fang; Yang, Shu-Long

Li, Meng-di; Wang, Yi-Fan; Yang, Mei-Wen; Hong, Fen-Fang; Yang, Shu-Long.

Afiliación

Li MD; Department of Physiology, College of Medicine, Nanchang University, Nanchang 330006, China.
Wang YF; Institute of Cancer Research, Jiangxi Academy of Medical Science, Nanchang, Jiangxi 330006, China.
Yang MW; Department of Nursing, Nanchang University hospital, Nanchang, Jiangxi 330006, China.
Hong FF; Department of Experimental Teaching Center, Nanchang University, Nanchang 330031, China.
Yang SL; Department of Physiology, College of Medicine, Nanchang University, Nanchang 330006, China.

Curr Med Chem ; 27(35): 6057-6072, 2020.

Article en En | MEDLINE | ID: mdl-31419926

Asunto(s)

Tromboangitis Obliterante; Autoinmunidad; Humanos; Factores de Riesgo; Fumar/efectos adversos; Tromboangitis Obliterante/etiología; Tromboangitis Obliterante/terapia; Resultado del Tratamiento

Palabras clave

Thromboangiitis obliterans; buerger's disease; clinical features of TAO; pathological mechanism; risk-factors; treatments

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Tromboangitis Obliterante Tipo de estudio: Etiology_studies / Risk_factors_studies Idioma: En Revista: Curr Med Chem Asunto de la revista: QUIMICA Año: 2020 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google